California State Teachers Retirement System Has $1.27 Million Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

California State Teachers Retirement System decreased its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 1.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 24,639 shares of the medical instruments supplier’s stock after selling 322 shares during the period. California State Teachers Retirement System owned approximately 0.11% of LeMaitre Vascular worth $1,268,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Fifth Third Bancorp raised its holdings in shares of LeMaitre Vascular by 1.3% in the first quarter. Fifth Third Bancorp now owns 13,775 shares of the medical instruments supplier’s stock valued at $709,000 after purchasing an additional 182 shares during the last quarter. Legal & General Group Plc raised its holdings in shares of LeMaitre Vascular by 0.4% in the second quarter. Legal & General Group Plc now owns 45,769 shares of the medical instruments supplier’s stock valued at $2,084,000 after purchasing an additional 200 shares during the last quarter. Arizona State Retirement System raised its holdings in shares of LeMaitre Vascular by 3.9% in the fourth quarter. Arizona State Retirement System now owns 5,577 shares of the medical instruments supplier’s stock valued at $257,000 after purchasing an additional 208 shares during the last quarter. Sei Investments Co. raised its holdings in shares of LeMaitre Vascular by 0.8% in the fourth quarter. Sei Investments Co. now owns 30,471 shares of the medical instruments supplier’s stock valued at $1,402,000 after purchasing an additional 248 shares during the last quarter. Finally, Advisor Group Holdings Inc. raised its holdings in shares of LeMaitre Vascular by 1.8% in the fourth quarter. Advisor Group Holdings Inc. now owns 22,313 shares of the medical instruments supplier’s stock valued at $1,027,000 after purchasing an additional 386 shares during the last quarter. Institutional investors and hedge funds own 84.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Jefferies Financial Group lowered shares of LeMaitre Vascular from a “buy” rating to a “hold” rating and increased their price target for the company from $63.00 to $67.00 in a research report on Thursday, August 3rd. Barrington Research increased their price target on shares of LeMaitre Vascular from $62.00 to $66.00 and gave the company an “outperform” rating in a research report on Wednesday, August 2nd. StockNews.com assumed coverage on shares of LeMaitre Vascular in a research report on Thursday, August 17th. They set a “buy” rating for the company. Finally, Lake Street Capital increased their target price on shares of LeMaitre Vascular from $65.00 to $75.00 and gave the stock a “buy” rating in a research report on Wednesday, August 2nd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, LeMaitre Vascular presently has a consensus rating of “Moderate Buy” and an average price target of $69.33.

LeMaitre Vascular Trading Down 1.5 %

LMAT stock opened at $57.81 on Friday. The firm has a 50 day moving average of $61.58 and a 200-day moving average of $58.23. LeMaitre Vascular, Inc. has a 12 month low of $41.78 and a 12 month high of $68.67. The firm has a market capitalization of $1.29 billion, a P/E ratio of 51.16, a price-to-earnings-growth ratio of 4.42 and a beta of 0.96.

LeMaitre Vascular (NASDAQ:LMAT) last released its quarterly earnings data on Tuesday, August 1st. The medical instruments supplier reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.32 by $0.05. LeMaitre Vascular had a net margin of 14.23% and a return on equity of 9.33%. The company had revenue of $50.12 million during the quarter, compared to analyst estimates of $48.29 million. Sell-side analysts predict that LeMaitre Vascular, Inc. will post 1.3 EPS for the current year.

LeMaitre Vascular Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 31st. Stockholders of record on Thursday, August 17th were given a $0.14 dividend. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.97%. LeMaitre Vascular’s dividend payout ratio (DPR) is currently 49.56%.

About LeMaitre Vascular

LeMaitre Vascular, Inc designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system.